Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]Code Context
trigger_error($message, E_USER_DEPRECATED);
}
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.' $stackFrame = (int) 1 $trace = [ (int) 0 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php', 'line' => (int) 2421, 'function' => 'deprecationWarning', 'args' => [ (int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.' ] ], (int) 1 => [ 'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php', 'line' => (int) 73, 'function' => 'offsetGet', 'class' => 'Cake\Http\ServerRequest', 'object' => object(Cake\Http\ServerRequest) {}, 'type' => '->', 'args' => [ (int) 0 => 'catslug' ] ], (int) 2 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php', 'line' => (int) 610, 'function' => 'printArticle', 'class' => 'App\Controller\ArtileDetailController', 'object' => object(App\Controller\ArtileDetailController) {}, 'type' => '->', 'args' => [] ], (int) 3 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php', 'line' => (int) 120, 'function' => 'invokeAction', 'class' => 'Cake\Controller\Controller', 'object' => object(App\Controller\ArtileDetailController) {}, 'type' => '->', 'args' => [] ], (int) 4 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php', 'line' => (int) 94, 'function' => '_invoke', 'class' => 'Cake\Http\ActionDispatcher', 'object' => object(Cake\Http\ActionDispatcher) {}, 'type' => '->', 'args' => [ (int) 0 => object(App\Controller\ArtileDetailController) {} ] ], (int) 5 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php', 'line' => (int) 235, 'function' => 'dispatch', 'class' => 'Cake\Http\ActionDispatcher', 'object' => object(Cake\Http\ActionDispatcher) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 6 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Http\BaseApplication', 'object' => object(App\Application) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 7 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php', 'line' => (int) 162, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 8 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Routing\Middleware\RoutingMiddleware', 'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 9 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php', 'line' => (int) 88, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 10 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Routing\Middleware\AssetMiddleware', 'object' => object(Cake\Routing\Middleware\AssetMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 11 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php', 'line' => (int) 96, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 12 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware', 'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 13 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 51, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 14 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php', 'line' => (int) 98, 'function' => 'run', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\MiddlewareQueue) {}, (int) 1 => object(Cake\Http\ServerRequest) {}, (int) 2 => object(Cake\Http\Response) {} ] ], (int) 15 => [ 'file' => '/home/brlfuser/public_html/webroot/index.php', 'line' => (int) 39, 'function' => 'run', 'class' => 'Cake\Http\Server', 'object' => object(Cake\Http\Server) {}, 'type' => '->', 'args' => [] ] ] $frame = [ 'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php', 'line' => (int) 73, 'function' => 'offsetGet', 'class' => 'Cake\Http\ServerRequest', 'object' => object(Cake\Http\ServerRequest) { trustProxy => false [protected] params => [ [maximum depth reached] ] [protected] data => [[maximum depth reached]] [protected] query => [[maximum depth reached]] [protected] cookies => [ [maximum depth reached] ] [protected] _environment => [ [maximum depth reached] ] [protected] url => 'latest-news-updates/max-super-specialty-made-excessive-profits-on-disposable-syringes-cci-4683381/print' [protected] base => '' [protected] webroot => '/' [protected] here => '/latest-news-updates/max-super-specialty-made-excessive-profits-on-disposable-syringes-cci-4683381/print' [protected] trustedProxies => [[maximum depth reached]] [protected] _input => null [protected] _detectors => [ [maximum depth reached] ] [protected] _detectorCache => [ [maximum depth reached] ] [protected] stream => object(Zend\Diactoros\PhpInputStream) {} [protected] uri => object(Zend\Diactoros\Uri) {} [protected] session => object(Cake\Http\Session) {} [protected] attributes => [[maximum depth reached]] [protected] emulatedAttributes => [ [maximum depth reached] ] [protected] uploadedFiles => [[maximum depth reached]] [protected] protocol => null [protected] requestTarget => null [private] deprecatedProperties => [ [maximum depth reached] ] }, 'type' => '->', 'args' => [ (int) 0 => 'catslug' ] ]deprecationWarning - CORE/src/Core/functions.php, line 311 Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421 App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73 Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51 Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98
Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]Code Context
trigger_error($message, E_USER_DEPRECATED);
}
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.' $stackFrame = (int) 1 $trace = [ (int) 0 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php', 'line' => (int) 2421, 'function' => 'deprecationWarning', 'args' => [ (int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.' ] ], (int) 1 => [ 'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php', 'line' => (int) 74, 'function' => 'offsetGet', 'class' => 'Cake\Http\ServerRequest', 'object' => object(Cake\Http\ServerRequest) {}, 'type' => '->', 'args' => [ (int) 0 => 'artileslug' ] ], (int) 2 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php', 'line' => (int) 610, 'function' => 'printArticle', 'class' => 'App\Controller\ArtileDetailController', 'object' => object(App\Controller\ArtileDetailController) {}, 'type' => '->', 'args' => [] ], (int) 3 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php', 'line' => (int) 120, 'function' => 'invokeAction', 'class' => 'Cake\Controller\Controller', 'object' => object(App\Controller\ArtileDetailController) {}, 'type' => '->', 'args' => [] ], (int) 4 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php', 'line' => (int) 94, 'function' => '_invoke', 'class' => 'Cake\Http\ActionDispatcher', 'object' => object(Cake\Http\ActionDispatcher) {}, 'type' => '->', 'args' => [ (int) 0 => object(App\Controller\ArtileDetailController) {} ] ], (int) 5 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php', 'line' => (int) 235, 'function' => 'dispatch', 'class' => 'Cake\Http\ActionDispatcher', 'object' => object(Cake\Http\ActionDispatcher) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 6 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Http\BaseApplication', 'object' => object(App\Application) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 7 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php', 'line' => (int) 162, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 8 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Routing\Middleware\RoutingMiddleware', 'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 9 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php', 'line' => (int) 88, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 10 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Routing\Middleware\AssetMiddleware', 'object' => object(Cake\Routing\Middleware\AssetMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 11 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php', 'line' => (int) 96, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 12 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware', 'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 13 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 51, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 14 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php', 'line' => (int) 98, 'function' => 'run', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\MiddlewareQueue) {}, (int) 1 => object(Cake\Http\ServerRequest) {}, (int) 2 => object(Cake\Http\Response) {} ] ], (int) 15 => [ 'file' => '/home/brlfuser/public_html/webroot/index.php', 'line' => (int) 39, 'function' => 'run', 'class' => 'Cake\Http\Server', 'object' => object(Cake\Http\Server) {}, 'type' => '->', 'args' => [] ] ] $frame = [ 'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php', 'line' => (int) 74, 'function' => 'offsetGet', 'class' => 'Cake\Http\ServerRequest', 'object' => object(Cake\Http\ServerRequest) { trustProxy => false [protected] params => [ [maximum depth reached] ] [protected] data => [[maximum depth reached]] [protected] query => [[maximum depth reached]] [protected] cookies => [ [maximum depth reached] ] [protected] _environment => [ [maximum depth reached] ] [protected] url => 'latest-news-updates/max-super-specialty-made-excessive-profits-on-disposable-syringes-cci-4683381/print' [protected] base => '' [protected] webroot => '/' [protected] here => '/latest-news-updates/max-super-specialty-made-excessive-profits-on-disposable-syringes-cci-4683381/print' [protected] trustedProxies => [[maximum depth reached]] [protected] _input => null [protected] _detectors => [ [maximum depth reached] ] [protected] _detectorCache => [ [maximum depth reached] ] [protected] stream => object(Zend\Diactoros\PhpInputStream) {} [protected] uri => object(Zend\Diactoros\Uri) {} [protected] session => object(Cake\Http\Session) {} [protected] attributes => [[maximum depth reached]] [protected] emulatedAttributes => [ [maximum depth reached] ] [protected] uploadedFiles => [[maximum depth reached]] [protected] protocol => null [protected] requestTarget => null [private] deprecatedProperties => [ [maximum depth reached] ] }, 'type' => '->', 'args' => [ (int) 0 => 'artileslug' ] ]deprecationWarning - CORE/src/Core/functions.php, line 311 Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421 App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74 Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51 Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98
Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]Code Contextif (Configure::read('debug')) {
trigger_error($message, E_USER_WARNING);
} else {
$response = object(Cake\Http\Response) { 'status' => (int) 200, 'contentType' => 'text/html', 'headers' => [ 'Content-Type' => [ [maximum depth reached] ] ], 'file' => null, 'fileRange' => [], 'cookies' => object(Cake\Http\Cookie\CookieCollection) {}, 'cacheDirectives' => [], 'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"> <html xmlns="http://www.w3.org/1999/xhtml"> <head> <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr6802e17aaa2bc-trace').style.display = (document.getElementById('cakeErr6802e17aaa2bc-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr6802e17aaa2bc-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr6802e17aaa2bc-code').style.display = (document.getElementById('cakeErr6802e17aaa2bc-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr6802e17aaa2bc-context').style.display = (document.getElementById('cakeErr6802e17aaa2bc-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr6802e17aaa2bc-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700"><</span><span style="color: #0000BB">head</span><span style="color: #007700">> </span></span></code> <span class="code-highlight"><code><span style="color: #000000"> <link rel="canonical" href="<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">); </span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">category</span><span style="color: #007700">-></span><span style="color: #0000BB">slug</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>/<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">seo_url</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>.html"/> </span></code></span> <code><span style="color: #000000"><span style="color: #0000BB"> </span><span style="color: #007700"><</span><span style="color: #0000BB">meta http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type" </span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html; charset=utf-8"</span><span style="color: #007700">/> </span></span></code></pre><pre id="cakeErr6802e17aaa2bc-context" class="cake-context" style="display: none;">$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp' $dataForView = [ 'article_current' => object(App\Model\Entity\Article) { 'id' => (int) 35274, 'title' => 'Max Super Specialty made excessive profits on disposable syringes: CCI', 'subheading' => '', 'description' => '<div align="justify"> -The Economic Times<br /> <br /> Max Super Specialty, Patparganj has made &ldquo;unfair&rdquo; and &ldquo;excessive&rdquo; profits on the sale of disposable syringes to patients admitted in its hospital, an investigation by the Competition Commission of India has revealed. The commission is expected to hold a hearing on this issue on December 20.<br /> <br /> CCI in 2015 ordered a probe into allegations that the hospital had colluded with multinational syringe maker Becton Dickinson&rsquo;s Indian arm to sell a particular brand of disposable syringes for nearly twice its open market price.<br /> <br /> Delhi-based lawyer Vijay Sharma, who filed the complaint, claimed he purchased Becton Dickinson India's disposable syringe brand 'Emerald' from Max Patparganj's in-house pharmacy for Rs 19.50 as per the Maximum Retail Price (MRP).<br /> <br /> Yet, he claimed he was charged only Rs 10 for the same syringe at a medical store outside the hospital. The product's MRP there was much lower at Rs 11.50 even though both the products were of the same name, quality, quantity, standard and manufactured by Becton Dickinson India, he alleged. <br /> <br /> An investigation report submitted to CCI in May this year has found Max in violation of provisions in the Competition Act of 2002 that prevent enterprises or groups from abusing their &ldquo;dominant&rdquo; position in a given market. ET has viewed a copy of this report.<br /> <br /> The investigation has found that the syringe purchased by Sharma from Max in Patparganj cannot be said to be identical to the one he purchased from the medical store outside the hospital.<br /> <br /> According to the report, the products belong to two different categories of syringes manufactured by Becton Dickinson&mdash;'flow wrap' syringes, priced at Rs 11.50 and 'blister pack' syringes, which carry a higher MRP of Rs19.50.<br /> <br /> The investigation noted that Max shifted to higher MRP blister pack syringes from flow wrap syringes in 2015-16 from 2014-15 and this appears to be to earn higher profit margins. The margins noted in the investigation were not reasonable or for the benefit of the customers on sale of syringes, according to the report.<br /> <br /> Please <a href="https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/max-super-specialty-made-excessive-profits-on-disposable-syringes-cci/articleshow/61954949.cms?utm_source=WAPusers&amp;utm_medium=twittershare&amp;utm_campaign=socialsharebutton&amp;from=mdr">click here</a> to read more. <br /> </div>', 'credit_writer' => 'The Economic Times, 7 December, 2017, https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/max-super-specialty-made-excessive-profits-on-disposable-syringes-cci/articleshow/6195', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'max-super-specialty-made-excessive-profits-on-disposable-syringes-cci-4683381', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 4683381, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ [maximum depth reached] ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ [maximum depth reached] ], '[dirty]' => [[maximum depth reached]], '[original]' => [[maximum depth reached]], '[virtual]' => [[maximum depth reached]], '[hasErrors]' => false, '[errors]' => [[maximum depth reached]], '[invalid]' => [[maximum depth reached]], '[repository]' => 'Articles' }, 'articleid' => (int) 35274, 'metaTitle' => 'LATEST NEWS UPDATES | Max Super Specialty made excessive profits on disposable syringes: CCI', 'metaKeywords' => 'Competition Commission of India,Competition Commission of India (CCI),Max Super Specialty Hospital,Unfair Trade Practices', 'metaDesc' => ' -The Economic Times Max Super Specialty, Patparganj has made &ldquo;unfair&rdquo; and &ldquo;excessive&rdquo; profits on the sale of disposable syringes to patients admitted in its hospital, an investigation by the Competition Commission of India has revealed. The commission is expected to hold...', 'disp' => '<div align="justify">-The Economic Times<br /><br />Max Super Specialty, Patparganj has made &ldquo;unfair&rdquo; and &ldquo;excessive&rdquo; profits on the sale of disposable syringes to patients admitted in its hospital, an investigation by the Competition Commission of India has revealed. The commission is expected to hold a hearing on this issue on December 20.<br /><br />CCI in 2015 ordered a probe into allegations that the hospital had colluded with multinational syringe maker Becton Dickinson&rsquo;s Indian arm to sell a particular brand of disposable syringes for nearly twice its open market price.<br /><br />Delhi-based lawyer Vijay Sharma, who filed the complaint, claimed he purchased Becton Dickinson India's disposable syringe brand 'Emerald' from Max Patparganj's in-house pharmacy for Rs 19.50 as per the Maximum Retail Price (MRP).<br /><br />Yet, he claimed he was charged only Rs 10 for the same syringe at a medical store outside the hospital. The product's MRP there was much lower at Rs 11.50 even though both the products were of the same name, quality, quantity, standard and manufactured by Becton Dickinson India, he alleged. <br /><br />An investigation report submitted to CCI in May this year has found Max in violation of provisions in the Competition Act of 2002 that prevent enterprises or groups from abusing their &ldquo;dominant&rdquo; position in a given market. ET has viewed a copy of this report.<br /><br />The investigation has found that the syringe purchased by Sharma from Max in Patparganj cannot be said to be identical to the one he purchased from the medical store outside the hospital.<br /><br />According to the report, the products belong to two different categories of syringes manufactured by Becton Dickinson&mdash;'flow wrap' syringes, priced at Rs 11.50 and 'blister pack' syringes, which carry a higher MRP of Rs19.50.<br /><br />The investigation noted that Max shifted to higher MRP blister pack syringes from flow wrap syringes in 2015-16 from 2014-15 and this appears to be to earn higher profit margins. The margins noted in the investigation were not reasonable or for the benefit of the customers on sale of syringes, according to the report.<br /><br />Please <a href="https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/max-super-specialty-made-excessive-profits-on-disposable-syringes-cci/articleshow/61954949.cms?utm_source=WAPusers&amp;utm_medium=twittershare&amp;utm_campaign=socialsharebutton&amp;from=mdr" title="https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/max-super-specialty-made-excessive-profits-on-disposable-syringes-cci/articleshow/61954949.cms?utm_source=WAPusers&amp;utm_medium=twittershare&amp;utm_campaign=socialsharebutton&amp;from=mdr">click here</a> to read more. <br /></div>', 'lang' => 'English', 'SITE_URL' => 'https://im4change.in/', 'site_title' => 'im4change', 'adminprix' => 'admin' ] $article_current = object(App\Model\Entity\Article) { 'id' => (int) 35274, 'title' => 'Max Super Specialty made excessive profits on disposable syringes: CCI', 'subheading' => '', 'description' => '<div align="justify"> -The Economic Times<br /> <br /> Max Super Specialty, Patparganj has made &ldquo;unfair&rdquo; and &ldquo;excessive&rdquo; profits on the sale of disposable syringes to patients admitted in its hospital, an investigation by the Competition Commission of India has revealed. The commission is expected to hold a hearing on this issue on December 20.<br /> <br /> CCI in 2015 ordered a probe into allegations that the hospital had colluded with multinational syringe maker Becton Dickinson&rsquo;s Indian arm to sell a particular brand of disposable syringes for nearly twice its open market price.<br /> <br /> Delhi-based lawyer Vijay Sharma, who filed the complaint, claimed he purchased Becton Dickinson India's disposable syringe brand 'Emerald' from Max Patparganj's in-house pharmacy for Rs 19.50 as per the Maximum Retail Price (MRP).<br /> <br /> Yet, he claimed he was charged only Rs 10 for the same syringe at a medical store outside the hospital. The product's MRP there was much lower at Rs 11.50 even though both the products were of the same name, quality, quantity, standard and manufactured by Becton Dickinson India, he alleged. <br /> <br /> An investigation report submitted to CCI in May this year has found Max in violation of provisions in the Competition Act of 2002 that prevent enterprises or groups from abusing their &ldquo;dominant&rdquo; position in a given market. ET has viewed a copy of this report.<br /> <br /> The investigation has found that the syringe purchased by Sharma from Max in Patparganj cannot be said to be identical to the one he purchased from the medical store outside the hospital.<br /> <br /> According to the report, the products belong to two different categories of syringes manufactured by Becton Dickinson&mdash;'flow wrap' syringes, priced at Rs 11.50 and 'blister pack' syringes, which carry a higher MRP of Rs19.50.<br /> <br /> The investigation noted that Max shifted to higher MRP blister pack syringes from flow wrap syringes in 2015-16 from 2014-15 and this appears to be to earn higher profit margins. The margins noted in the investigation were not reasonable or for the benefit of the customers on sale of syringes, according to the report.<br /> <br /> Please <a href="https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/max-super-specialty-made-excessive-profits-on-disposable-syringes-cci/articleshow/61954949.cms?utm_source=WAPusers&amp;utm_medium=twittershare&amp;utm_campaign=socialsharebutton&amp;from=mdr">click here</a> to read more. <br /> </div>', 'credit_writer' => 'The Economic Times, 7 December, 2017, https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/max-super-specialty-made-excessive-profits-on-disposable-syringes-cci/articleshow/6195', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'max-super-specialty-made-excessive-profits-on-disposable-syringes-cci-4683381', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 4683381, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ (int) 0 => object(Cake\ORM\Entity) {}, (int) 1 => object(Cake\ORM\Entity) {}, (int) 2 => object(Cake\ORM\Entity) {}, (int) 3 => object(Cake\ORM\Entity) {} ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ '*' => true, 'id' => false ], '[dirty]' => [], '[original]' => [], '[virtual]' => [], '[hasErrors]' => false, '[errors]' => [], '[invalid]' => [], '[repository]' => 'Articles' } $articleid = (int) 35274 $metaTitle = 'LATEST NEWS UPDATES | Max Super Specialty made excessive profits on disposable syringes: CCI' $metaKeywords = 'Competition Commission of India,Competition Commission of India (CCI),Max Super Specialty Hospital,Unfair Trade Practices' $metaDesc = ' -The Economic Times Max Super Specialty, Patparganj has made &ldquo;unfair&rdquo; and &ldquo;excessive&rdquo; profits on the sale of disposable syringes to patients admitted in its hospital, an investigation by the Competition Commission of India has revealed. The commission is expected to hold...' $disp = '<div align="justify">-The Economic Times<br /><br />Max Super Specialty, Patparganj has made &ldquo;unfair&rdquo; and &ldquo;excessive&rdquo; profits on the sale of disposable syringes to patients admitted in its hospital, an investigation by the Competition Commission of India has revealed. The commission is expected to hold a hearing on this issue on December 20.<br /><br />CCI in 2015 ordered a probe into allegations that the hospital had colluded with multinational syringe maker Becton Dickinson&rsquo;s Indian arm to sell a particular brand of disposable syringes for nearly twice its open market price.<br /><br />Delhi-based lawyer Vijay Sharma, who filed the complaint, claimed he purchased Becton Dickinson India's disposable syringe brand 'Emerald' from Max Patparganj's in-house pharmacy for Rs 19.50 as per the Maximum Retail Price (MRP).<br /><br />Yet, he claimed he was charged only Rs 10 for the same syringe at a medical store outside the hospital. The product's MRP there was much lower at Rs 11.50 even though both the products were of the same name, quality, quantity, standard and manufactured by Becton Dickinson India, he alleged. <br /><br />An investigation report submitted to CCI in May this year has found Max in violation of provisions in the Competition Act of 2002 that prevent enterprises or groups from abusing their &ldquo;dominant&rdquo; position in a given market. ET has viewed a copy of this report.<br /><br />The investigation has found that the syringe purchased by Sharma from Max in Patparganj cannot be said to be identical to the one he purchased from the medical store outside the hospital.<br /><br />According to the report, the products belong to two different categories of syringes manufactured by Becton Dickinson&mdash;'flow wrap' syringes, priced at Rs 11.50 and 'blister pack' syringes, which carry a higher MRP of Rs19.50.<br /><br />The investigation noted that Max shifted to higher MRP blister pack syringes from flow wrap syringes in 2015-16 from 2014-15 and this appears to be to earn higher profit margins. The margins noted in the investigation were not reasonable or for the benefit of the customers on sale of syringes, according to the report.<br /><br />Please <a href="https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/max-super-specialty-made-excessive-profits-on-disposable-syringes-cci/articleshow/61954949.cms?utm_source=WAPusers&amp;utm_medium=twittershare&amp;utm_campaign=socialsharebutton&amp;from=mdr" title="https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/max-super-specialty-made-excessive-profits-on-disposable-syringes-cci/articleshow/61954949.cms?utm_source=WAPusers&amp;utm_medium=twittershare&amp;utm_campaign=socialsharebutton&amp;from=mdr">click here</a> to read more. <br /></div>' $lang = 'English' $SITE_URL = 'https://im4change.in/' $site_title = 'im4change' $adminprix = 'admin'</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8 Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413 Cake\View\View::_render() - CORE/src/View/View.php, line 1374 Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927 Cake\View\View::render() - CORE/src/View/View.php, line 885 Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/max-super-specialty-made-excessive-profits-on-disposable-syringes-cci-4683381.html"/> <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/> <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css" media="all"/> <title>LATEST NEWS UPDATES | Max Super Specialty made excessive profits on disposable syringes: CCI | Im4change.org</title> <meta name="description" content=" -The Economic Times Max Super Specialty, Patparganj has made “unfair” and “excessive” profits on the sale of disposable syringes to patients admitted in its hospital, an investigation by the Competition Commission of India has revealed. The commission is expected to hold..."/> <script src="https://im4change.in/js/jquery-1.10.2.js"></script> <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script> <script language="javascript" type="text/javascript"> $(document).ready(function () { var img = $("img")[0]; // Get my img elem var pic_real_width, pic_real_height; $("<img/>") // Make in memory copy of image to avoid css issues .attr("src", $(img).attr("src")) .load(function () { pic_real_width = this.width; // Note: $(this).width() will not pic_real_height = this.height; // work for in memory images. }); }); </script> <style type="text/css"> @media screen { div.divFooter { display: block; } } @media print { .printbutton { display: none !important; } } </style> </head> <body> <table cellpadding="0" cellspacing="0" border="0" width="98%" align="center"> <tr> <td class="top_bg"> <div class="divFooter"> <img src="https://im4change.in/images/logo1.jpg" height="59" border="0" alt="Resource centre on India's rural distress" style="padding-top:14px;"/> </div> </td> </tr> <tr> <td id="topspace"> </td> </tr> <tr id="topspace"> <td> </td> </tr> <tr> <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> <tr> <td width="100%"> <h1 class="news_headlines" style="font-style:normal"> <strong>Max Super Specialty made excessive profits on disposable syringes: CCI</strong></h1> </td> </tr> <tr> <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3"> <div align="justify">-The Economic Times<br /><br />Max Super Specialty, Patparganj has made “unfair” and “excessive” profits on the sale of disposable syringes to patients admitted in its hospital, an investigation by the Competition Commission of India has revealed. The commission is expected to hold a hearing on this issue on December 20.<br /><br />CCI in 2015 ordered a probe into allegations that the hospital had colluded with multinational syringe maker Becton Dickinson’s Indian arm to sell a particular brand of disposable syringes for nearly twice its open market price.<br /><br />Delhi-based lawyer Vijay Sharma, who filed the complaint, claimed he purchased Becton Dickinson India's disposable syringe brand 'Emerald' from Max Patparganj's in-house pharmacy for Rs 19.50 as per the Maximum Retail Price (MRP).<br /><br />Yet, he claimed he was charged only Rs 10 for the same syringe at a medical store outside the hospital. The product's MRP there was much lower at Rs 11.50 even though both the products were of the same name, quality, quantity, standard and manufactured by Becton Dickinson India, he alleged. <br /><br />An investigation report submitted to CCI in May this year has found Max in violation of provisions in the Competition Act of 2002 that prevent enterprises or groups from abusing their “dominant” position in a given market. ET has viewed a copy of this report.<br /><br />The investigation has found that the syringe purchased by Sharma from Max in Patparganj cannot be said to be identical to the one he purchased from the medical store outside the hospital.<br /><br />According to the report, the products belong to two different categories of syringes manufactured by Becton Dickinson—'flow wrap' syringes, priced at Rs 11.50 and 'blister pack' syringes, which carry a higher MRP of Rs19.50.<br /><br />The investigation noted that Max shifted to higher MRP blister pack syringes from flow wrap syringes in 2015-16 from 2014-15 and this appears to be to earn higher profit margins. The margins noted in the investigation were not reasonable or for the benefit of the customers on sale of syringes, according to the report.<br /><br />Please <a href="https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/max-super-specialty-made-excessive-profits-on-disposable-syringes-cci/articleshow/61954949.cms?utm_source=WAPusers&utm_medium=twittershare&utm_campaign=socialsharebutton&from=mdr" title="https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/max-super-specialty-made-excessive-profits-on-disposable-syringes-cci/articleshow/61954949.cms?utm_source=WAPusers&utm_medium=twittershare&utm_campaign=socialsharebutton&from=mdr">click here</a> to read more. <br /></div> </font> </td> </tr> <tr> <td> </td> </tr> <tr> <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> </table></body> </html>' } $maxBufferLength = (int) 8192 $file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php' $line = (int) 853 $message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48 Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141 [main] - ROOT/webroot/index.php, line 39
Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]Code Context$response->getStatusCode(),
($reasonPhrase ? ' ' . $reasonPhrase : '')
));
$response = object(Cake\Http\Response) { 'status' => (int) 200, 'contentType' => 'text/html', 'headers' => [ 'Content-Type' => [ [maximum depth reached] ] ], 'file' => null, 'fileRange' => [], 'cookies' => object(Cake\Http\Cookie\CookieCollection) {}, 'cacheDirectives' => [], 'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"> <html xmlns="http://www.w3.org/1999/xhtml"> <head> <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr6802e17aaa2bc-trace').style.display = (document.getElementById('cakeErr6802e17aaa2bc-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr6802e17aaa2bc-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr6802e17aaa2bc-code').style.display = (document.getElementById('cakeErr6802e17aaa2bc-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr6802e17aaa2bc-context').style.display = (document.getElementById('cakeErr6802e17aaa2bc-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr6802e17aaa2bc-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700"><</span><span style="color: #0000BB">head</span><span style="color: #007700">> </span></span></code> <span class="code-highlight"><code><span style="color: #000000"> <link rel="canonical" href="<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">); </span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">category</span><span style="color: #007700">-></span><span style="color: #0000BB">slug</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>/<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">seo_url</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>.html"/> </span></code></span> <code><span style="color: #000000"><span style="color: #0000BB"> </span><span style="color: #007700"><</span><span style="color: #0000BB">meta http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type" </span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html; charset=utf-8"</span><span style="color: #007700">/> </span></span></code></pre><pre id="cakeErr6802e17aaa2bc-context" class="cake-context" style="display: none;">$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp' $dataForView = [ 'article_current' => object(App\Model\Entity\Article) { 'id' => (int) 35274, 'title' => 'Max Super Specialty made excessive profits on disposable syringes: CCI', 'subheading' => '', 'description' => '<div align="justify"> -The Economic Times<br /> <br /> Max Super Specialty, Patparganj has made &ldquo;unfair&rdquo; and &ldquo;excessive&rdquo; profits on the sale of disposable syringes to patients admitted in its hospital, an investigation by the Competition Commission of India has revealed. The commission is expected to hold a hearing on this issue on December 20.<br /> <br /> CCI in 2015 ordered a probe into allegations that the hospital had colluded with multinational syringe maker Becton Dickinson&rsquo;s Indian arm to sell a particular brand of disposable syringes for nearly twice its open market price.<br /> <br /> Delhi-based lawyer Vijay Sharma, who filed the complaint, claimed he purchased Becton Dickinson India's disposable syringe brand 'Emerald' from Max Patparganj's in-house pharmacy for Rs 19.50 as per the Maximum Retail Price (MRP).<br /> <br /> Yet, he claimed he was charged only Rs 10 for the same syringe at a medical store outside the hospital. The product's MRP there was much lower at Rs 11.50 even though both the products were of the same name, quality, quantity, standard and manufactured by Becton Dickinson India, he alleged. <br /> <br /> An investigation report submitted to CCI in May this year has found Max in violation of provisions in the Competition Act of 2002 that prevent enterprises or groups from abusing their &ldquo;dominant&rdquo; position in a given market. ET has viewed a copy of this report.<br /> <br /> The investigation has found that the syringe purchased by Sharma from Max in Patparganj cannot be said to be identical to the one he purchased from the medical store outside the hospital.<br /> <br /> According to the report, the products belong to two different categories of syringes manufactured by Becton Dickinson&mdash;'flow wrap' syringes, priced at Rs 11.50 and 'blister pack' syringes, which carry a higher MRP of Rs19.50.<br /> <br /> The investigation noted that Max shifted to higher MRP blister pack syringes from flow wrap syringes in 2015-16 from 2014-15 and this appears to be to earn higher profit margins. The margins noted in the investigation were not reasonable or for the benefit of the customers on sale of syringes, according to the report.<br /> <br /> Please <a href="https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/max-super-specialty-made-excessive-profits-on-disposable-syringes-cci/articleshow/61954949.cms?utm_source=WAPusers&amp;utm_medium=twittershare&amp;utm_campaign=socialsharebutton&amp;from=mdr">click here</a> to read more. <br /> </div>', 'credit_writer' => 'The Economic Times, 7 December, 2017, https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/max-super-specialty-made-excessive-profits-on-disposable-syringes-cci/articleshow/6195', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'max-super-specialty-made-excessive-profits-on-disposable-syringes-cci-4683381', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 4683381, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ [maximum depth reached] ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ [maximum depth reached] ], '[dirty]' => [[maximum depth reached]], '[original]' => [[maximum depth reached]], '[virtual]' => [[maximum depth reached]], '[hasErrors]' => false, '[errors]' => [[maximum depth reached]], '[invalid]' => [[maximum depth reached]], '[repository]' => 'Articles' }, 'articleid' => (int) 35274, 'metaTitle' => 'LATEST NEWS UPDATES | Max Super Specialty made excessive profits on disposable syringes: CCI', 'metaKeywords' => 'Competition Commission of India,Competition Commission of India (CCI),Max Super Specialty Hospital,Unfair Trade Practices', 'metaDesc' => ' -The Economic Times Max Super Specialty, Patparganj has made &ldquo;unfair&rdquo; and &ldquo;excessive&rdquo; profits on the sale of disposable syringes to patients admitted in its hospital, an investigation by the Competition Commission of India has revealed. The commission is expected to hold...', 'disp' => '<div align="justify">-The Economic Times<br /><br />Max Super Specialty, Patparganj has made &ldquo;unfair&rdquo; and &ldquo;excessive&rdquo; profits on the sale of disposable syringes to patients admitted in its hospital, an investigation by the Competition Commission of India has revealed. The commission is expected to hold a hearing on this issue on December 20.<br /><br />CCI in 2015 ordered a probe into allegations that the hospital had colluded with multinational syringe maker Becton Dickinson&rsquo;s Indian arm to sell a particular brand of disposable syringes for nearly twice its open market price.<br /><br />Delhi-based lawyer Vijay Sharma, who filed the complaint, claimed he purchased Becton Dickinson India's disposable syringe brand 'Emerald' from Max Patparganj's in-house pharmacy for Rs 19.50 as per the Maximum Retail Price (MRP).<br /><br />Yet, he claimed he was charged only Rs 10 for the same syringe at a medical store outside the hospital. The product's MRP there was much lower at Rs 11.50 even though both the products were of the same name, quality, quantity, standard and manufactured by Becton Dickinson India, he alleged. <br /><br />An investigation report submitted to CCI in May this year has found Max in violation of provisions in the Competition Act of 2002 that prevent enterprises or groups from abusing their &ldquo;dominant&rdquo; position in a given market. ET has viewed a copy of this report.<br /><br />The investigation has found that the syringe purchased by Sharma from Max in Patparganj cannot be said to be identical to the one he purchased from the medical store outside the hospital.<br /><br />According to the report, the products belong to two different categories of syringes manufactured by Becton Dickinson&mdash;'flow wrap' syringes, priced at Rs 11.50 and 'blister pack' syringes, which carry a higher MRP of Rs19.50.<br /><br />The investigation noted that Max shifted to higher MRP blister pack syringes from flow wrap syringes in 2015-16 from 2014-15 and this appears to be to earn higher profit margins. The margins noted in the investigation were not reasonable or for the benefit of the customers on sale of syringes, according to the report.<br /><br />Please <a href="https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/max-super-specialty-made-excessive-profits-on-disposable-syringes-cci/articleshow/61954949.cms?utm_source=WAPusers&amp;utm_medium=twittershare&amp;utm_campaign=socialsharebutton&amp;from=mdr" title="https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/max-super-specialty-made-excessive-profits-on-disposable-syringes-cci/articleshow/61954949.cms?utm_source=WAPusers&amp;utm_medium=twittershare&amp;utm_campaign=socialsharebutton&amp;from=mdr">click here</a> to read more. <br /></div>', 'lang' => 'English', 'SITE_URL' => 'https://im4change.in/', 'site_title' => 'im4change', 'adminprix' => 'admin' ] $article_current = object(App\Model\Entity\Article) { 'id' => (int) 35274, 'title' => 'Max Super Specialty made excessive profits on disposable syringes: CCI', 'subheading' => '', 'description' => '<div align="justify"> -The Economic Times<br /> <br /> Max Super Specialty, Patparganj has made &ldquo;unfair&rdquo; and &ldquo;excessive&rdquo; profits on the sale of disposable syringes to patients admitted in its hospital, an investigation by the Competition Commission of India has revealed. The commission is expected to hold a hearing on this issue on December 20.<br /> <br /> CCI in 2015 ordered a probe into allegations that the hospital had colluded with multinational syringe maker Becton Dickinson&rsquo;s Indian arm to sell a particular brand of disposable syringes for nearly twice its open market price.<br /> <br /> Delhi-based lawyer Vijay Sharma, who filed the complaint, claimed he purchased Becton Dickinson India's disposable syringe brand 'Emerald' from Max Patparganj's in-house pharmacy for Rs 19.50 as per the Maximum Retail Price (MRP).<br /> <br /> Yet, he claimed he was charged only Rs 10 for the same syringe at a medical store outside the hospital. The product's MRP there was much lower at Rs 11.50 even though both the products were of the same name, quality, quantity, standard and manufactured by Becton Dickinson India, he alleged. <br /> <br /> An investigation report submitted to CCI in May this year has found Max in violation of provisions in the Competition Act of 2002 that prevent enterprises or groups from abusing their &ldquo;dominant&rdquo; position in a given market. ET has viewed a copy of this report.<br /> <br /> The investigation has found that the syringe purchased by Sharma from Max in Patparganj cannot be said to be identical to the one he purchased from the medical store outside the hospital.<br /> <br /> According to the report, the products belong to two different categories of syringes manufactured by Becton Dickinson&mdash;'flow wrap' syringes, priced at Rs 11.50 and 'blister pack' syringes, which carry a higher MRP of Rs19.50.<br /> <br /> The investigation noted that Max shifted to higher MRP blister pack syringes from flow wrap syringes in 2015-16 from 2014-15 and this appears to be to earn higher profit margins. The margins noted in the investigation were not reasonable or for the benefit of the customers on sale of syringes, according to the report.<br /> <br /> Please <a href="https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/max-super-specialty-made-excessive-profits-on-disposable-syringes-cci/articleshow/61954949.cms?utm_source=WAPusers&amp;utm_medium=twittershare&amp;utm_campaign=socialsharebutton&amp;from=mdr">click here</a> to read more. <br /> </div>', 'credit_writer' => 'The Economic Times, 7 December, 2017, https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/max-super-specialty-made-excessive-profits-on-disposable-syringes-cci/articleshow/6195', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'max-super-specialty-made-excessive-profits-on-disposable-syringes-cci-4683381', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 4683381, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ (int) 0 => object(Cake\ORM\Entity) {}, (int) 1 => object(Cake\ORM\Entity) {}, (int) 2 => object(Cake\ORM\Entity) {}, (int) 3 => object(Cake\ORM\Entity) {} ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ '*' => true, 'id' => false ], '[dirty]' => [], '[original]' => [], '[virtual]' => [], '[hasErrors]' => false, '[errors]' => [], '[invalid]' => [], '[repository]' => 'Articles' } $articleid = (int) 35274 $metaTitle = 'LATEST NEWS UPDATES | Max Super Specialty made excessive profits on disposable syringes: CCI' $metaKeywords = 'Competition Commission of India,Competition Commission of India (CCI),Max Super Specialty Hospital,Unfair Trade Practices' $metaDesc = ' -The Economic Times Max Super Specialty, Patparganj has made &ldquo;unfair&rdquo; and &ldquo;excessive&rdquo; profits on the sale of disposable syringes to patients admitted in its hospital, an investigation by the Competition Commission of India has revealed. The commission is expected to hold...' $disp = '<div align="justify">-The Economic Times<br /><br />Max Super Specialty, Patparganj has made &ldquo;unfair&rdquo; and &ldquo;excessive&rdquo; profits on the sale of disposable syringes to patients admitted in its hospital, an investigation by the Competition Commission of India has revealed. The commission is expected to hold a hearing on this issue on December 20.<br /><br />CCI in 2015 ordered a probe into allegations that the hospital had colluded with multinational syringe maker Becton Dickinson&rsquo;s Indian arm to sell a particular brand of disposable syringes for nearly twice its open market price.<br /><br />Delhi-based lawyer Vijay Sharma, who filed the complaint, claimed he purchased Becton Dickinson India's disposable syringe brand 'Emerald' from Max Patparganj's in-house pharmacy for Rs 19.50 as per the Maximum Retail Price (MRP).<br /><br />Yet, he claimed he was charged only Rs 10 for the same syringe at a medical store outside the hospital. The product's MRP there was much lower at Rs 11.50 even though both the products were of the same name, quality, quantity, standard and manufactured by Becton Dickinson India, he alleged. <br /><br />An investigation report submitted to CCI in May this year has found Max in violation of provisions in the Competition Act of 2002 that prevent enterprises or groups from abusing their &ldquo;dominant&rdquo; position in a given market. ET has viewed a copy of this report.<br /><br />The investigation has found that the syringe purchased by Sharma from Max in Patparganj cannot be said to be identical to the one he purchased from the medical store outside the hospital.<br /><br />According to the report, the products belong to two different categories of syringes manufactured by Becton Dickinson&mdash;'flow wrap' syringes, priced at Rs 11.50 and 'blister pack' syringes, which carry a higher MRP of Rs19.50.<br /><br />The investigation noted that Max shifted to higher MRP blister pack syringes from flow wrap syringes in 2015-16 from 2014-15 and this appears to be to earn higher profit margins. The margins noted in the investigation were not reasonable or for the benefit of the customers on sale of syringes, according to the report.<br /><br />Please <a href="https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/max-super-specialty-made-excessive-profits-on-disposable-syringes-cci/articleshow/61954949.cms?utm_source=WAPusers&amp;utm_medium=twittershare&amp;utm_campaign=socialsharebutton&amp;from=mdr" title="https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/max-super-specialty-made-excessive-profits-on-disposable-syringes-cci/articleshow/61954949.cms?utm_source=WAPusers&amp;utm_medium=twittershare&amp;utm_campaign=socialsharebutton&amp;from=mdr">click here</a> to read more. <br /></div>' $lang = 'English' $SITE_URL = 'https://im4change.in/' $site_title = 'im4change' $adminprix = 'admin'</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8 Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413 Cake\View\View::_render() - CORE/src/View/View.php, line 1374 Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927 Cake\View\View::render() - CORE/src/View/View.php, line 885 Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/max-super-specialty-made-excessive-profits-on-disposable-syringes-cci-4683381.html"/> <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/> <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css" media="all"/> <title>LATEST NEWS UPDATES | Max Super Specialty made excessive profits on disposable syringes: CCI | Im4change.org</title> <meta name="description" content=" -The Economic Times Max Super Specialty, Patparganj has made “unfair” and “excessive” profits on the sale of disposable syringes to patients admitted in its hospital, an investigation by the Competition Commission of India has revealed. The commission is expected to hold..."/> <script src="https://im4change.in/js/jquery-1.10.2.js"></script> <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script> <script language="javascript" type="text/javascript"> $(document).ready(function () { var img = $("img")[0]; // Get my img elem var pic_real_width, pic_real_height; $("<img/>") // Make in memory copy of image to avoid css issues .attr("src", $(img).attr("src")) .load(function () { pic_real_width = this.width; // Note: $(this).width() will not pic_real_height = this.height; // work for in memory images. }); }); </script> <style type="text/css"> @media screen { div.divFooter { display: block; } } @media print { .printbutton { display: none !important; } } </style> </head> <body> <table cellpadding="0" cellspacing="0" border="0" width="98%" align="center"> <tr> <td class="top_bg"> <div class="divFooter"> <img src="https://im4change.in/images/logo1.jpg" height="59" border="0" alt="Resource centre on India's rural distress" style="padding-top:14px;"/> </div> </td> </tr> <tr> <td id="topspace"> </td> </tr> <tr id="topspace"> <td> </td> </tr> <tr> <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> <tr> <td width="100%"> <h1 class="news_headlines" style="font-style:normal"> <strong>Max Super Specialty made excessive profits on disposable syringes: CCI</strong></h1> </td> </tr> <tr> <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3"> <div align="justify">-The Economic Times<br /><br />Max Super Specialty, Patparganj has made “unfair” and “excessive” profits on the sale of disposable syringes to patients admitted in its hospital, an investigation by the Competition Commission of India has revealed. The commission is expected to hold a hearing on this issue on December 20.<br /><br />CCI in 2015 ordered a probe into allegations that the hospital had colluded with multinational syringe maker Becton Dickinson’s Indian arm to sell a particular brand of disposable syringes for nearly twice its open market price.<br /><br />Delhi-based lawyer Vijay Sharma, who filed the complaint, claimed he purchased Becton Dickinson India's disposable syringe brand 'Emerald' from Max Patparganj's in-house pharmacy for Rs 19.50 as per the Maximum Retail Price (MRP).<br /><br />Yet, he claimed he was charged only Rs 10 for the same syringe at a medical store outside the hospital. The product's MRP there was much lower at Rs 11.50 even though both the products were of the same name, quality, quantity, standard and manufactured by Becton Dickinson India, he alleged. <br /><br />An investigation report submitted to CCI in May this year has found Max in violation of provisions in the Competition Act of 2002 that prevent enterprises or groups from abusing their “dominant” position in a given market. ET has viewed a copy of this report.<br /><br />The investigation has found that the syringe purchased by Sharma from Max in Patparganj cannot be said to be identical to the one he purchased from the medical store outside the hospital.<br /><br />According to the report, the products belong to two different categories of syringes manufactured by Becton Dickinson—'flow wrap' syringes, priced at Rs 11.50 and 'blister pack' syringes, which carry a higher MRP of Rs19.50.<br /><br />The investigation noted that Max shifted to higher MRP blister pack syringes from flow wrap syringes in 2015-16 from 2014-15 and this appears to be to earn higher profit margins. The margins noted in the investigation were not reasonable or for the benefit of the customers on sale of syringes, according to the report.<br /><br />Please <a href="https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/max-super-specialty-made-excessive-profits-on-disposable-syringes-cci/articleshow/61954949.cms?utm_source=WAPusers&utm_medium=twittershare&utm_campaign=socialsharebutton&from=mdr" title="https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/max-super-specialty-made-excessive-profits-on-disposable-syringes-cci/articleshow/61954949.cms?utm_source=WAPusers&utm_medium=twittershare&utm_campaign=socialsharebutton&from=mdr">click here</a> to read more. <br /></div> </font> </td> </tr> <tr> <td> </td> </tr> <tr> <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> </table></body> </html>' } $reasonPhrase = 'OK'header - [internal], line ?? Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148 Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54 Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141 [main] - ROOT/webroot/index.php, line 39
Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]Notice (8): Undefined variable: urlPrefix [APP/Template/Layout/printlayout.ctp, line 8]Code Context$value
), $first);
$first = false;
$response = object(Cake\Http\Response) { 'status' => (int) 200, 'contentType' => 'text/html', 'headers' => [ 'Content-Type' => [ [maximum depth reached] ] ], 'file' => null, 'fileRange' => [], 'cookies' => object(Cake\Http\Cookie\CookieCollection) {}, 'cacheDirectives' => [], 'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"> <html xmlns="http://www.w3.org/1999/xhtml"> <head> <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr6802e17aaa2bc-trace').style.display = (document.getElementById('cakeErr6802e17aaa2bc-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr6802e17aaa2bc-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr6802e17aaa2bc-code').style.display = (document.getElementById('cakeErr6802e17aaa2bc-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr6802e17aaa2bc-context').style.display = (document.getElementById('cakeErr6802e17aaa2bc-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr6802e17aaa2bc-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700"><</span><span style="color: #0000BB">head</span><span style="color: #007700">> </span></span></code> <span class="code-highlight"><code><span style="color: #000000"> <link rel="canonical" href="<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">); </span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">category</span><span style="color: #007700">-></span><span style="color: #0000BB">slug</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>/<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">seo_url</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>.html"/> </span></code></span> <code><span style="color: #000000"><span style="color: #0000BB"> </span><span style="color: #007700"><</span><span style="color: #0000BB">meta http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type" </span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html; charset=utf-8"</span><span style="color: #007700">/> </span></span></code></pre><pre id="cakeErr6802e17aaa2bc-context" class="cake-context" style="display: none;">$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp' $dataForView = [ 'article_current' => object(App\Model\Entity\Article) { 'id' => (int) 35274, 'title' => 'Max Super Specialty made excessive profits on disposable syringes: CCI', 'subheading' => '', 'description' => '<div align="justify"> -The Economic Times<br /> <br /> Max Super Specialty, Patparganj has made &ldquo;unfair&rdquo; and &ldquo;excessive&rdquo; profits on the sale of disposable syringes to patients admitted in its hospital, an investigation by the Competition Commission of India has revealed. The commission is expected to hold a hearing on this issue on December 20.<br /> <br /> CCI in 2015 ordered a probe into allegations that the hospital had colluded with multinational syringe maker Becton Dickinson&rsquo;s Indian arm to sell a particular brand of disposable syringes for nearly twice its open market price.<br /> <br /> Delhi-based lawyer Vijay Sharma, who filed the complaint, claimed he purchased Becton Dickinson India's disposable syringe brand 'Emerald' from Max Patparganj's in-house pharmacy for Rs 19.50 as per the Maximum Retail Price (MRP).<br /> <br /> Yet, he claimed he was charged only Rs 10 for the same syringe at a medical store outside the hospital. The product's MRP there was much lower at Rs 11.50 even though both the products were of the same name, quality, quantity, standard and manufactured by Becton Dickinson India, he alleged. <br /> <br /> An investigation report submitted to CCI in May this year has found Max in violation of provisions in the Competition Act of 2002 that prevent enterprises or groups from abusing their &ldquo;dominant&rdquo; position in a given market. ET has viewed a copy of this report.<br /> <br /> The investigation has found that the syringe purchased by Sharma from Max in Patparganj cannot be said to be identical to the one he purchased from the medical store outside the hospital.<br /> <br /> According to the report, the products belong to two different categories of syringes manufactured by Becton Dickinson&mdash;'flow wrap' syringes, priced at Rs 11.50 and 'blister pack' syringes, which carry a higher MRP of Rs19.50.<br /> <br /> The investigation noted that Max shifted to higher MRP blister pack syringes from flow wrap syringes in 2015-16 from 2014-15 and this appears to be to earn higher profit margins. The margins noted in the investigation were not reasonable or for the benefit of the customers on sale of syringes, according to the report.<br /> <br /> Please <a href="https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/max-super-specialty-made-excessive-profits-on-disposable-syringes-cci/articleshow/61954949.cms?utm_source=WAPusers&amp;utm_medium=twittershare&amp;utm_campaign=socialsharebutton&amp;from=mdr">click here</a> to read more. <br /> </div>', 'credit_writer' => 'The Economic Times, 7 December, 2017, https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/max-super-specialty-made-excessive-profits-on-disposable-syringes-cci/articleshow/6195', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'max-super-specialty-made-excessive-profits-on-disposable-syringes-cci-4683381', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 4683381, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ [maximum depth reached] ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ [maximum depth reached] ], '[dirty]' => [[maximum depth reached]], '[original]' => [[maximum depth reached]], '[virtual]' => [[maximum depth reached]], '[hasErrors]' => false, '[errors]' => [[maximum depth reached]], '[invalid]' => [[maximum depth reached]], '[repository]' => 'Articles' }, 'articleid' => (int) 35274, 'metaTitle' => 'LATEST NEWS UPDATES | Max Super Specialty made excessive profits on disposable syringes: CCI', 'metaKeywords' => 'Competition Commission of India,Competition Commission of India (CCI),Max Super Specialty Hospital,Unfair Trade Practices', 'metaDesc' => ' -The Economic Times Max Super Specialty, Patparganj has made &ldquo;unfair&rdquo; and &ldquo;excessive&rdquo; profits on the sale of disposable syringes to patients admitted in its hospital, an investigation by the Competition Commission of India has revealed. The commission is expected to hold...', 'disp' => '<div align="justify">-The Economic Times<br /><br />Max Super Specialty, Patparganj has made &ldquo;unfair&rdquo; and &ldquo;excessive&rdquo; profits on the sale of disposable syringes to patients admitted in its hospital, an investigation by the Competition Commission of India has revealed. The commission is expected to hold a hearing on this issue on December 20.<br /><br />CCI in 2015 ordered a probe into allegations that the hospital had colluded with multinational syringe maker Becton Dickinson&rsquo;s Indian arm to sell a particular brand of disposable syringes for nearly twice its open market price.<br /><br />Delhi-based lawyer Vijay Sharma, who filed the complaint, claimed he purchased Becton Dickinson India's disposable syringe brand 'Emerald' from Max Patparganj's in-house pharmacy for Rs 19.50 as per the Maximum Retail Price (MRP).<br /><br />Yet, he claimed he was charged only Rs 10 for the same syringe at a medical store outside the hospital. The product's MRP there was much lower at Rs 11.50 even though both the products were of the same name, quality, quantity, standard and manufactured by Becton Dickinson India, he alleged. <br /><br />An investigation report submitted to CCI in May this year has found Max in violation of provisions in the Competition Act of 2002 that prevent enterprises or groups from abusing their &ldquo;dominant&rdquo; position in a given market. ET has viewed a copy of this report.<br /><br />The investigation has found that the syringe purchased by Sharma from Max in Patparganj cannot be said to be identical to the one he purchased from the medical store outside the hospital.<br /><br />According to the report, the products belong to two different categories of syringes manufactured by Becton Dickinson&mdash;'flow wrap' syringes, priced at Rs 11.50 and 'blister pack' syringes, which carry a higher MRP of Rs19.50.<br /><br />The investigation noted that Max shifted to higher MRP blister pack syringes from flow wrap syringes in 2015-16 from 2014-15 and this appears to be to earn higher profit margins. The margins noted in the investigation were not reasonable or for the benefit of the customers on sale of syringes, according to the report.<br /><br />Please <a href="https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/max-super-specialty-made-excessive-profits-on-disposable-syringes-cci/articleshow/61954949.cms?utm_source=WAPusers&amp;utm_medium=twittershare&amp;utm_campaign=socialsharebutton&amp;from=mdr" title="https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/max-super-specialty-made-excessive-profits-on-disposable-syringes-cci/articleshow/61954949.cms?utm_source=WAPusers&amp;utm_medium=twittershare&amp;utm_campaign=socialsharebutton&amp;from=mdr">click here</a> to read more. <br /></div>', 'lang' => 'English', 'SITE_URL' => 'https://im4change.in/', 'site_title' => 'im4change', 'adminprix' => 'admin' ] $article_current = object(App\Model\Entity\Article) { 'id' => (int) 35274, 'title' => 'Max Super Specialty made excessive profits on disposable syringes: CCI', 'subheading' => '', 'description' => '<div align="justify"> -The Economic Times<br /> <br /> Max Super Specialty, Patparganj has made &ldquo;unfair&rdquo; and &ldquo;excessive&rdquo; profits on the sale of disposable syringes to patients admitted in its hospital, an investigation by the Competition Commission of India has revealed. The commission is expected to hold a hearing on this issue on December 20.<br /> <br /> CCI in 2015 ordered a probe into allegations that the hospital had colluded with multinational syringe maker Becton Dickinson&rsquo;s Indian arm to sell a particular brand of disposable syringes for nearly twice its open market price.<br /> <br /> Delhi-based lawyer Vijay Sharma, who filed the complaint, claimed he purchased Becton Dickinson India's disposable syringe brand 'Emerald' from Max Patparganj's in-house pharmacy for Rs 19.50 as per the Maximum Retail Price (MRP).<br /> <br /> Yet, he claimed he was charged only Rs 10 for the same syringe at a medical store outside the hospital. The product's MRP there was much lower at Rs 11.50 even though both the products were of the same name, quality, quantity, standard and manufactured by Becton Dickinson India, he alleged. <br /> <br /> An investigation report submitted to CCI in May this year has found Max in violation of provisions in the Competition Act of 2002 that prevent enterprises or groups from abusing their &ldquo;dominant&rdquo; position in a given market. ET has viewed a copy of this report.<br /> <br /> The investigation has found that the syringe purchased by Sharma from Max in Patparganj cannot be said to be identical to the one he purchased from the medical store outside the hospital.<br /> <br /> According to the report, the products belong to two different categories of syringes manufactured by Becton Dickinson&mdash;'flow wrap' syringes, priced at Rs 11.50 and 'blister pack' syringes, which carry a higher MRP of Rs19.50.<br /> <br /> The investigation noted that Max shifted to higher MRP blister pack syringes from flow wrap syringes in 2015-16 from 2014-15 and this appears to be to earn higher profit margins. The margins noted in the investigation were not reasonable or for the benefit of the customers on sale of syringes, according to the report.<br /> <br /> Please <a href="https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/max-super-specialty-made-excessive-profits-on-disposable-syringes-cci/articleshow/61954949.cms?utm_source=WAPusers&amp;utm_medium=twittershare&amp;utm_campaign=socialsharebutton&amp;from=mdr">click here</a> to read more. <br /> </div>', 'credit_writer' => 'The Economic Times, 7 December, 2017, https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/max-super-specialty-made-excessive-profits-on-disposable-syringes-cci/articleshow/6195', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'max-super-specialty-made-excessive-profits-on-disposable-syringes-cci-4683381', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 4683381, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ (int) 0 => object(Cake\ORM\Entity) {}, (int) 1 => object(Cake\ORM\Entity) {}, (int) 2 => object(Cake\ORM\Entity) {}, (int) 3 => object(Cake\ORM\Entity) {} ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ '*' => true, 'id' => false ], '[dirty]' => [], '[original]' => [], '[virtual]' => [], '[hasErrors]' => false, '[errors]' => [], '[invalid]' => [], '[repository]' => 'Articles' } $articleid = (int) 35274 $metaTitle = 'LATEST NEWS UPDATES | Max Super Specialty made excessive profits on disposable syringes: CCI' $metaKeywords = 'Competition Commission of India,Competition Commission of India (CCI),Max Super Specialty Hospital,Unfair Trade Practices' $metaDesc = ' -The Economic Times Max Super Specialty, Patparganj has made &ldquo;unfair&rdquo; and &ldquo;excessive&rdquo; profits on the sale of disposable syringes to patients admitted in its hospital, an investigation by the Competition Commission of India has revealed. The commission is expected to hold...' $disp = '<div align="justify">-The Economic Times<br /><br />Max Super Specialty, Patparganj has made &ldquo;unfair&rdquo; and &ldquo;excessive&rdquo; profits on the sale of disposable syringes to patients admitted in its hospital, an investigation by the Competition Commission of India has revealed. The commission is expected to hold a hearing on this issue on December 20.<br /><br />CCI in 2015 ordered a probe into allegations that the hospital had colluded with multinational syringe maker Becton Dickinson&rsquo;s Indian arm to sell a particular brand of disposable syringes for nearly twice its open market price.<br /><br />Delhi-based lawyer Vijay Sharma, who filed the complaint, claimed he purchased Becton Dickinson India's disposable syringe brand 'Emerald' from Max Patparganj's in-house pharmacy for Rs 19.50 as per the Maximum Retail Price (MRP).<br /><br />Yet, he claimed he was charged only Rs 10 for the same syringe at a medical store outside the hospital. The product's MRP there was much lower at Rs 11.50 even though both the products were of the same name, quality, quantity, standard and manufactured by Becton Dickinson India, he alleged. <br /><br />An investigation report submitted to CCI in May this year has found Max in violation of provisions in the Competition Act of 2002 that prevent enterprises or groups from abusing their &ldquo;dominant&rdquo; position in a given market. ET has viewed a copy of this report.<br /><br />The investigation has found that the syringe purchased by Sharma from Max in Patparganj cannot be said to be identical to the one he purchased from the medical store outside the hospital.<br /><br />According to the report, the products belong to two different categories of syringes manufactured by Becton Dickinson&mdash;'flow wrap' syringes, priced at Rs 11.50 and 'blister pack' syringes, which carry a higher MRP of Rs19.50.<br /><br />The investigation noted that Max shifted to higher MRP blister pack syringes from flow wrap syringes in 2015-16 from 2014-15 and this appears to be to earn higher profit margins. The margins noted in the investigation were not reasonable or for the benefit of the customers on sale of syringes, according to the report.<br /><br />Please <a href="https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/max-super-specialty-made-excessive-profits-on-disposable-syringes-cci/articleshow/61954949.cms?utm_source=WAPusers&amp;utm_medium=twittershare&amp;utm_campaign=socialsharebutton&amp;from=mdr" title="https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/max-super-specialty-made-excessive-profits-on-disposable-syringes-cci/articleshow/61954949.cms?utm_source=WAPusers&amp;utm_medium=twittershare&amp;utm_campaign=socialsharebutton&amp;from=mdr">click here</a> to read more. <br /></div>' $lang = 'English' $SITE_URL = 'https://im4change.in/' $site_title = 'im4change' $adminprix = 'admin'</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8 Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413 Cake\View\View::_render() - CORE/src/View/View.php, line 1374 Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927 Cake\View\View::render() - CORE/src/View/View.php, line 885 Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/max-super-specialty-made-excessive-profits-on-disposable-syringes-cci-4683381.html"/> <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/> <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css" media="all"/> <title>LATEST NEWS UPDATES | Max Super Specialty made excessive profits on disposable syringes: CCI | Im4change.org</title> <meta name="description" content=" -The Economic Times Max Super Specialty, Patparganj has made “unfair” and “excessive” profits on the sale of disposable syringes to patients admitted in its hospital, an investigation by the Competition Commission of India has revealed. The commission is expected to hold..."/> <script src="https://im4change.in/js/jquery-1.10.2.js"></script> <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script> <script language="javascript" type="text/javascript"> $(document).ready(function () { var img = $("img")[0]; // Get my img elem var pic_real_width, pic_real_height; $("<img/>") // Make in memory copy of image to avoid css issues .attr("src", $(img).attr("src")) .load(function () { pic_real_width = this.width; // Note: $(this).width() will not pic_real_height = this.height; // work for in memory images. }); }); </script> <style type="text/css"> @media screen { div.divFooter { display: block; } } @media print { .printbutton { display: none !important; } } </style> </head> <body> <table cellpadding="0" cellspacing="0" border="0" width="98%" align="center"> <tr> <td class="top_bg"> <div class="divFooter"> <img src="https://im4change.in/images/logo1.jpg" height="59" border="0" alt="Resource centre on India's rural distress" style="padding-top:14px;"/> </div> </td> </tr> <tr> <td id="topspace"> </td> </tr> <tr id="topspace"> <td> </td> </tr> <tr> <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> <tr> <td width="100%"> <h1 class="news_headlines" style="font-style:normal"> <strong>Max Super Specialty made excessive profits on disposable syringes: CCI</strong></h1> </td> </tr> <tr> <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3"> <div align="justify">-The Economic Times<br /><br />Max Super Specialty, Patparganj has made “unfair” and “excessive” profits on the sale of disposable syringes to patients admitted in its hospital, an investigation by the Competition Commission of India has revealed. The commission is expected to hold a hearing on this issue on December 20.<br /><br />CCI in 2015 ordered a probe into allegations that the hospital had colluded with multinational syringe maker Becton Dickinson’s Indian arm to sell a particular brand of disposable syringes for nearly twice its open market price.<br /><br />Delhi-based lawyer Vijay Sharma, who filed the complaint, claimed he purchased Becton Dickinson India's disposable syringe brand 'Emerald' from Max Patparganj's in-house pharmacy for Rs 19.50 as per the Maximum Retail Price (MRP).<br /><br />Yet, he claimed he was charged only Rs 10 for the same syringe at a medical store outside the hospital. The product's MRP there was much lower at Rs 11.50 even though both the products were of the same name, quality, quantity, standard and manufactured by Becton Dickinson India, he alleged. <br /><br />An investigation report submitted to CCI in May this year has found Max in violation of provisions in the Competition Act of 2002 that prevent enterprises or groups from abusing their “dominant” position in a given market. ET has viewed a copy of this report.<br /><br />The investigation has found that the syringe purchased by Sharma from Max in Patparganj cannot be said to be identical to the one he purchased from the medical store outside the hospital.<br /><br />According to the report, the products belong to two different categories of syringes manufactured by Becton Dickinson—'flow wrap' syringes, priced at Rs 11.50 and 'blister pack' syringes, which carry a higher MRP of Rs19.50.<br /><br />The investigation noted that Max shifted to higher MRP blister pack syringes from flow wrap syringes in 2015-16 from 2014-15 and this appears to be to earn higher profit margins. The margins noted in the investigation were not reasonable or for the benefit of the customers on sale of syringes, according to the report.<br /><br />Please <a href="https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/max-super-specialty-made-excessive-profits-on-disposable-syringes-cci/articleshow/61954949.cms?utm_source=WAPusers&utm_medium=twittershare&utm_campaign=socialsharebutton&from=mdr" title="https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/max-super-specialty-made-excessive-profits-on-disposable-syringes-cci/articleshow/61954949.cms?utm_source=WAPusers&utm_medium=twittershare&utm_campaign=socialsharebutton&from=mdr">click here</a> to read more. <br /></div> </font> </td> </tr> <tr> <td> </td> </tr> <tr> <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> </table></body> </html>' } $cookies = [] $values = [ (int) 0 => 'text/html; charset=UTF-8' ] $name = 'Content-Type' $first = true $value = 'text/html; charset=UTF-8'header - [internal], line ?? Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181 Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55 Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141 [main] - ROOT/webroot/index.php, line 39
<head>
<link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp' $dataForView = [ 'article_current' => object(App\Model\Entity\Article) { 'id' => (int) 35274, 'title' => 'Max Super Specialty made excessive profits on disposable syringes: CCI', 'subheading' => '', 'description' => '<div align="justify"> -The Economic Times<br /> <br /> Max Super Specialty, Patparganj has made “unfair” and “excessive” profits on the sale of disposable syringes to patients admitted in its hospital, an investigation by the Competition Commission of India has revealed. The commission is expected to hold a hearing on this issue on December 20.<br /> <br /> CCI in 2015 ordered a probe into allegations that the hospital had colluded with multinational syringe maker Becton Dickinson’s Indian arm to sell a particular brand of disposable syringes for nearly twice its open market price.<br /> <br /> Delhi-based lawyer Vijay Sharma, who filed the complaint, claimed he purchased Becton Dickinson India's disposable syringe brand 'Emerald' from Max Patparganj's in-house pharmacy for Rs 19.50 as per the Maximum Retail Price (MRP).<br /> <br /> Yet, he claimed he was charged only Rs 10 for the same syringe at a medical store outside the hospital. The product's MRP there was much lower at Rs 11.50 even though both the products were of the same name, quality, quantity, standard and manufactured by Becton Dickinson India, he alleged. <br /> <br /> An investigation report submitted to CCI in May this year has found Max in violation of provisions in the Competition Act of 2002 that prevent enterprises or groups from abusing their “dominant” position in a given market. ET has viewed a copy of this report.<br /> <br /> The investigation has found that the syringe purchased by Sharma from Max in Patparganj cannot be said to be identical to the one he purchased from the medical store outside the hospital.<br /> <br /> According to the report, the products belong to two different categories of syringes manufactured by Becton Dickinson—'flow wrap' syringes, priced at Rs 11.50 and 'blister pack' syringes, which carry a higher MRP of Rs19.50.<br /> <br /> The investigation noted that Max shifted to higher MRP blister pack syringes from flow wrap syringes in 2015-16 from 2014-15 and this appears to be to earn higher profit margins. The margins noted in the investigation were not reasonable or for the benefit of the customers on sale of syringes, according to the report.<br /> <br /> Please <a href="https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/max-super-specialty-made-excessive-profits-on-disposable-syringes-cci/articleshow/61954949.cms?utm_source=WAPusers&utm_medium=twittershare&utm_campaign=socialsharebutton&from=mdr">click here</a> to read more. <br /> </div>', 'credit_writer' => 'The Economic Times, 7 December, 2017, https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/max-super-specialty-made-excessive-profits-on-disposable-syringes-cci/articleshow/6195', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'max-super-specialty-made-excessive-profits-on-disposable-syringes-cci-4683381', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 4683381, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ [maximum depth reached] ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ [maximum depth reached] ], '[dirty]' => [[maximum depth reached]], '[original]' => [[maximum depth reached]], '[virtual]' => [[maximum depth reached]], '[hasErrors]' => false, '[errors]' => [[maximum depth reached]], '[invalid]' => [[maximum depth reached]], '[repository]' => 'Articles' }, 'articleid' => (int) 35274, 'metaTitle' => 'LATEST NEWS UPDATES | Max Super Specialty made excessive profits on disposable syringes: CCI', 'metaKeywords' => 'Competition Commission of India,Competition Commission of India (CCI),Max Super Specialty Hospital,Unfair Trade Practices', 'metaDesc' => ' -The Economic Times Max Super Specialty, Patparganj has made “unfair” and “excessive” profits on the sale of disposable syringes to patients admitted in its hospital, an investigation by the Competition Commission of India has revealed. The commission is expected to hold...', 'disp' => '<div align="justify">-The Economic Times<br /><br />Max Super Specialty, Patparganj has made “unfair” and “excessive” profits on the sale of disposable syringes to patients admitted in its hospital, an investigation by the Competition Commission of India has revealed. The commission is expected to hold a hearing on this issue on December 20.<br /><br />CCI in 2015 ordered a probe into allegations that the hospital had colluded with multinational syringe maker Becton Dickinson’s Indian arm to sell a particular brand of disposable syringes for nearly twice its open market price.<br /><br />Delhi-based lawyer Vijay Sharma, who filed the complaint, claimed he purchased Becton Dickinson India's disposable syringe brand 'Emerald' from Max Patparganj's in-house pharmacy for Rs 19.50 as per the Maximum Retail Price (MRP).<br /><br />Yet, he claimed he was charged only Rs 10 for the same syringe at a medical store outside the hospital. The product's MRP there was much lower at Rs 11.50 even though both the products were of the same name, quality, quantity, standard and manufactured by Becton Dickinson India, he alleged. <br /><br />An investigation report submitted to CCI in May this year has found Max in violation of provisions in the Competition Act of 2002 that prevent enterprises or groups from abusing their “dominant” position in a given market. ET has viewed a copy of this report.<br /><br />The investigation has found that the syringe purchased by Sharma from Max in Patparganj cannot be said to be identical to the one he purchased from the medical store outside the hospital.<br /><br />According to the report, the products belong to two different categories of syringes manufactured by Becton Dickinson—'flow wrap' syringes, priced at Rs 11.50 and 'blister pack' syringes, which carry a higher MRP of Rs19.50.<br /><br />The investigation noted that Max shifted to higher MRP blister pack syringes from flow wrap syringes in 2015-16 from 2014-15 and this appears to be to earn higher profit margins. The margins noted in the investigation were not reasonable or for the benefit of the customers on sale of syringes, according to the report.<br /><br />Please <a href="https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/max-super-specialty-made-excessive-profits-on-disposable-syringes-cci/articleshow/61954949.cms?utm_source=WAPusers&utm_medium=twittershare&utm_campaign=socialsharebutton&from=mdr" title="https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/max-super-specialty-made-excessive-profits-on-disposable-syringes-cci/articleshow/61954949.cms?utm_source=WAPusers&utm_medium=twittershare&utm_campaign=socialsharebutton&from=mdr">click here</a> to read more. <br /></div>', 'lang' => 'English', 'SITE_URL' => 'https://im4change.in/', 'site_title' => 'im4change', 'adminprix' => 'admin' ] $article_current = object(App\Model\Entity\Article) { 'id' => (int) 35274, 'title' => 'Max Super Specialty made excessive profits on disposable syringes: CCI', 'subheading' => '', 'description' => '<div align="justify"> -The Economic Times<br /> <br /> Max Super Specialty, Patparganj has made “unfair” and “excessive” profits on the sale of disposable syringes to patients admitted in its hospital, an investigation by the Competition Commission of India has revealed. The commission is expected to hold a hearing on this issue on December 20.<br /> <br /> CCI in 2015 ordered a probe into allegations that the hospital had colluded with multinational syringe maker Becton Dickinson’s Indian arm to sell a particular brand of disposable syringes for nearly twice its open market price.<br /> <br /> Delhi-based lawyer Vijay Sharma, who filed the complaint, claimed he purchased Becton Dickinson India's disposable syringe brand 'Emerald' from Max Patparganj's in-house pharmacy for Rs 19.50 as per the Maximum Retail Price (MRP).<br /> <br /> Yet, he claimed he was charged only Rs 10 for the same syringe at a medical store outside the hospital. The product's MRP there was much lower at Rs 11.50 even though both the products were of the same name, quality, quantity, standard and manufactured by Becton Dickinson India, he alleged. <br /> <br /> An investigation report submitted to CCI in May this year has found Max in violation of provisions in the Competition Act of 2002 that prevent enterprises or groups from abusing their “dominant” position in a given market. ET has viewed a copy of this report.<br /> <br /> The investigation has found that the syringe purchased by Sharma from Max in Patparganj cannot be said to be identical to the one he purchased from the medical store outside the hospital.<br /> <br /> According to the report, the products belong to two different categories of syringes manufactured by Becton Dickinson—'flow wrap' syringes, priced at Rs 11.50 and 'blister pack' syringes, which carry a higher MRP of Rs19.50.<br /> <br /> The investigation noted that Max shifted to higher MRP blister pack syringes from flow wrap syringes in 2015-16 from 2014-15 and this appears to be to earn higher profit margins. The margins noted in the investigation were not reasonable or for the benefit of the customers on sale of syringes, according to the report.<br /> <br /> Please <a href="https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/max-super-specialty-made-excessive-profits-on-disposable-syringes-cci/articleshow/61954949.cms?utm_source=WAPusers&utm_medium=twittershare&utm_campaign=socialsharebutton&from=mdr">click here</a> to read more. <br /> </div>', 'credit_writer' => 'The Economic Times, 7 December, 2017, https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/max-super-specialty-made-excessive-profits-on-disposable-syringes-cci/articleshow/6195', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'max-super-specialty-made-excessive-profits-on-disposable-syringes-cci-4683381', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 4683381, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ (int) 0 => object(Cake\ORM\Entity) {}, (int) 1 => object(Cake\ORM\Entity) {}, (int) 2 => object(Cake\ORM\Entity) {}, (int) 3 => object(Cake\ORM\Entity) {} ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ '*' => true, 'id' => false ], '[dirty]' => [], '[original]' => [], '[virtual]' => [], '[hasErrors]' => false, '[errors]' => [], '[invalid]' => [], '[repository]' => 'Articles' } $articleid = (int) 35274 $metaTitle = 'LATEST NEWS UPDATES | Max Super Specialty made excessive profits on disposable syringes: CCI' $metaKeywords = 'Competition Commission of India,Competition Commission of India (CCI),Max Super Specialty Hospital,Unfair Trade Practices' $metaDesc = ' -The Economic Times Max Super Specialty, Patparganj has made “unfair” and “excessive” profits on the sale of disposable syringes to patients admitted in its hospital, an investigation by the Competition Commission of India has revealed. The commission is expected to hold...' $disp = '<div align="justify">-The Economic Times<br /><br />Max Super Specialty, Patparganj has made “unfair” and “excessive” profits on the sale of disposable syringes to patients admitted in its hospital, an investigation by the Competition Commission of India has revealed. The commission is expected to hold a hearing on this issue on December 20.<br /><br />CCI in 2015 ordered a probe into allegations that the hospital had colluded with multinational syringe maker Becton Dickinson’s Indian arm to sell a particular brand of disposable syringes for nearly twice its open market price.<br /><br />Delhi-based lawyer Vijay Sharma, who filed the complaint, claimed he purchased Becton Dickinson India's disposable syringe brand 'Emerald' from Max Patparganj's in-house pharmacy for Rs 19.50 as per the Maximum Retail Price (MRP).<br /><br />Yet, he claimed he was charged only Rs 10 for the same syringe at a medical store outside the hospital. The product's MRP there was much lower at Rs 11.50 even though both the products were of the same name, quality, quantity, standard and manufactured by Becton Dickinson India, he alleged. <br /><br />An investigation report submitted to CCI in May this year has found Max in violation of provisions in the Competition Act of 2002 that prevent enterprises or groups from abusing their “dominant” position in a given market. ET has viewed a copy of this report.<br /><br />The investigation has found that the syringe purchased by Sharma from Max in Patparganj cannot be said to be identical to the one he purchased from the medical store outside the hospital.<br /><br />According to the report, the products belong to two different categories of syringes manufactured by Becton Dickinson—'flow wrap' syringes, priced at Rs 11.50 and 'blister pack' syringes, which carry a higher MRP of Rs19.50.<br /><br />The investigation noted that Max shifted to higher MRP blister pack syringes from flow wrap syringes in 2015-16 from 2014-15 and this appears to be to earn higher profit margins. The margins noted in the investigation were not reasonable or for the benefit of the customers on sale of syringes, according to the report.<br /><br />Please <a href="https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/max-super-specialty-made-excessive-profits-on-disposable-syringes-cci/articleshow/61954949.cms?utm_source=WAPusers&utm_medium=twittershare&utm_campaign=socialsharebutton&from=mdr" title="https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/max-super-specialty-made-excessive-profits-on-disposable-syringes-cci/articleshow/61954949.cms?utm_source=WAPusers&utm_medium=twittershare&utm_campaign=socialsharebutton&from=mdr">click here</a> to read more. <br /></div>' $lang = 'English' $SITE_URL = 'https://im4change.in/' $site_title = 'im4change' $adminprix = 'admin'
include - APP/Template/Layout/printlayout.ctp, line 8 Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413 Cake\View\View::_render() - CORE/src/View/View.php, line 1374 Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927 Cake\View\View::render() - CORE/src/View/View.php, line 885 Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
![]() |
Max Super Specialty made excessive profits on disposable syringes: CCI |
-The Economic Times
Max Super Specialty, Patparganj has made “unfair” and “excessive” profits on the sale of disposable syringes to patients admitted in its hospital, an investigation by the Competition Commission of India has revealed. The commission is expected to hold a hearing on this issue on December 20. CCI in 2015 ordered a probe into allegations that the hospital had colluded with multinational syringe maker Becton Dickinson’s Indian arm to sell a particular brand of disposable syringes for nearly twice its open market price. Delhi-based lawyer Vijay Sharma, who filed the complaint, claimed he purchased Becton Dickinson India's disposable syringe brand 'Emerald' from Max Patparganj's in-house pharmacy for Rs 19.50 as per the Maximum Retail Price (MRP). Yet, he claimed he was charged only Rs 10 for the same syringe at a medical store outside the hospital. The product's MRP there was much lower at Rs 11.50 even though both the products were of the same name, quality, quantity, standard and manufactured by Becton Dickinson India, he alleged. An investigation report submitted to CCI in May this year has found Max in violation of provisions in the Competition Act of 2002 that prevent enterprises or groups from abusing their “dominant” position in a given market. ET has viewed a copy of this report. The investigation has found that the syringe purchased by Sharma from Max in Patparganj cannot be said to be identical to the one he purchased from the medical store outside the hospital. According to the report, the products belong to two different categories of syringes manufactured by Becton Dickinson—'flow wrap' syringes, priced at Rs 11.50 and 'blister pack' syringes, which carry a higher MRP of Rs19.50. The investigation noted that Max shifted to higher MRP blister pack syringes from flow wrap syringes in 2015-16 from 2014-15 and this appears to be to earn higher profit margins. The margins noted in the investigation were not reasonable or for the benefit of the customers on sale of syringes, according to the report. Please click here to read more. |